TerrAscend (TSNDF) Shares Outstanding (Weighted Average) (2020 - 2026)

TerrAscend (TSNDF) reported Shares Outstanding (Weighted Average) of $308.5 million for Q1 2026, up 5.26% year-over-year from $293.1 million in Q1 2025, and up 1226.82% quarter-over-quarter from $23.3 million in Q4 2025.

TerrAscend (TSNDF) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 7 years of Shares Outstanding (Weighted Average) data on file, last reported at $308.5 million in Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $308.5 million, up 5.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $308.5 million (up 5.26% YoY), and the FY2025 annual result was $301.1 million, up 1188.3% from the prior year.
  • Shares Outstanding (Weighted Average) grew to $308.5 million in Q1 2026 per TSNDF's latest filing, from $23.3 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $308.5 million in Q1 2026 and troughed at $3.6 million in Q4 2023.
  • A 5-year average of $144.5 million and a median of $127.7 million in 2022 frame the typical range for Shares Outstanding (Weighted Average).
  • The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Weighted Average) tumbled 99.87% in 2022, then jumped 8064.21% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $244.4 million in 2022, then slumped by 98.53% to $3.6 million in 2023, then surged by 550.93% to $23.4 million in 2024, then dropped by 0.5% to $23.3 million in 2025, then jumped by 1226.82% to $308.5 million in 2026.
  • Business Quant data shows TSNDF's Shares Outstanding (Weighted Average) at $308.5 million in Q1 2026, $23.3 million in Q4 2025, and $299.1 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.16 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 166.20 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 228.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 64.74 Mn
10 TerrAscend - - 34.60 Mn 308.53 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 308.53 Mn
Dec 31, 2025 23.25 Mn
Jun 30, 2025 299.09 Mn
Mar 31, 2025 293.12 Mn
Dec 31, 2024 23.37 Mn
Sep 30, 2024 23.56 Mn
Jun 30, 2024 291.49 Mn
Mar 31, 2024 3.59 Mn
Dec 31, 2023 3.59 Mn
Sep 30, 2023 10.72 Mn
Jun 30, 2023 10.72 Mn
Mar 31, 2023 267.21 Mn
Dec 31, 2022 244.35 Mn
Sep 30, 2022 254.36 Mn
Jun 30, 2022 231.83 Mn
Mar 31, 2022 23.29 Mn
Dec 31, 2021 31.00 Mn
Sep 30, 2021 179.44 Bn
Jun 30, 2021 182.37 Bn
Mar 31, 2021 171.37 Mn